These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15508446)

  • 1. [The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma].
    Fujii K; Okamoto S; Saitoh K; Sasaki N; Takano M; Tanaka S; Kudoh K; Kita T; Tode T; Kikuchi Y
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1537-40. PubMed ID: 15508446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of arthralgia and myalgia from paclitaxel and carboplatin combination chemotherapy with Shakuyaku-kanzo-to].
    Fujiwara H; Urabe T; Ueda K; Mizunoe T; Date K; Nakano M; Honda N; Sakashita T; Fujito N
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):1061-4. PubMed ID: 10925696
    [No Abstract]   [Full Text] [Related]  

  • 3. Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice.
    Hidaka T; Shima T; Nagira K; Ieki M; Nakamura T; Aono Y; Kuraishi Y; Arai T; Saito S
    Eur J Pain; 2009 Jan; 13(1):22-7. PubMed ID: 18472288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin.
    Yamamoto K; Hoshiai H; Noda K
    Gynecol Oncol; 2001 May; 81(2):333-4. PubMed ID: 11330975
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of L-Glutamine and Shakuyaku-Kanzo-to for paclitaxel-induced myalgia/arthralgia].
    Hasegawa K; Mizutani Y; Kuramoto H; Nagao S; Masuyama H; Hongo A; Kodama J; Yoshinouchi M; Hiramatsu Y; Kudo T; Okuda H
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):569-74. PubMed ID: 11977541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer.
    Yoshida T; Sawa T; Ishiguro T; Horiba A; Minatoguchi S; Fujiwara H
    Support Care Cancer; 2009 Mar; 17(3):315-20. PubMed ID: 18839222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study].
    Misawa A; Yasuda M
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on the efficacy of weekly paclitaxel administration for platinum-resistant epithelial ovarian carcinoma].
    Fujii K; Takano M; Okamoto S; Sasaki N; Kita T; Kikuchi Y
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2141-4. PubMed ID: 15628759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurotoxicity of weekly TP (weekly paclitaxel + consecutive low-dose CDDP) therapy].
    Tate S; Hirai Y; Iwasaki H; Matsui H; Sekiya S; Hasumi K
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):67-73. PubMed ID: 14750324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practical use of taxol-based chemotherapy for poor compliance gynecologic cancers in Japanese woman].
    Mitsui M; Takashi K; Imai K
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):383-9. PubMed ID: 12669398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
    Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ;
    J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
    Alberts DS; Marth C; Alvarez RD; Johnson G; Bidzinski M; Kardatzke DR; Bradford WZ; Loutit J; Kirn DH; Clouser MC; Markman M;
    Gynecol Oncol; 2008 May; 109(2):174-81. PubMed ID: 18314182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of pure-type ovarian squamous cell carcinoma for which combination chemotherapy consisting of paclitaxel and carboplatin was not effective.
    Todo Y; Minobe S; Sasaki M; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Apr; 97(1):223-7. PubMed ID: 15790463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer.
    Vapattanawong P
    J Med Assoc Thai; 2006 Sep; 89(9):1357-61. PubMed ID: 17100369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of orally administered shao-yao-gan-cao-tang (Shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients: a preliminary study.
    Hinoshita F; Ogura Y; Suzuki Y; Hara S; Yamada A; Tanaka N; Yamashita A; Marumo F
    Am J Chin Med; 2003; 31(3):445-53. PubMed ID: 12943175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD; Zhang Q; Zhang Y
    Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of adverse effects including neurotoxicity of combination chemotherapy with paclitaxel and carboplatin].
    Tate S; Iwasaki H; Matsui H; Hirai Y; Sekiya S
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2087-95. PubMed ID: 11103240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
    du Bois A; Weber B; Rochon J; Meier W; Goupil A; Olbricht S; Barats JC; Kuhn W; Orfeuvre H; Wagner U; Richter B; Lueck HJ; Pfisterer J; Costa S; Schroeder W; Kimmig R; Pujade-Lauraine E; ; ;
    J Clin Oncol; 2006 Mar; 24(7):1127-35. PubMed ID: 16505432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.